All Columns articles – Page 4
-
OpinionEmbracing oddities
When new chemistry looks like alchemy or witchcraft, it’s worth taking notice
-
OpinionWe’re all in this together
As rivalry between countries increases scientific collaboration must be maintained to tackle our shared problems
-
OpinionElizabeth Holmes to be imprisoned for Theranos fraud
Blood testing company founder’s 11-year sentence should serve as a warning to investors
-
OpinionThe incredible legacy of Tutankhamun
Three-thousand-year-old treasures can still enthral and inspire
-
OpinionWhy glycans?
Glycoscience is turning out to be more interesting than anyone might have imagined
-
OpinionTrouble at the top of the UK government spells trouble for science too
Science craves certainty but the UK hasn’t been able to deliver it recently
-
OpinionTwelve reasons for labs to go greener
How your lab can benefit from cutting energy, water and waste
-
OpinionNobel vision
Looking beyond the here-and-now let click chemistry open up a whole new world of possibility
-
BusinessAlzheimer’s antibody engenders anticipation
Tantalising press-released data on Biogen and Eisai’s lecanemab prompt questions without firm answers
-
OpinionKnocking down paywalls
President Biden’s surprise announcement ending paywalls for federally-funded research by 2026 has left publishers scrambling to respond
-
-
OpinionWhy AlphaFold won’t revolutionise drug discovery
Protein structure prediction is a hard problem, but even harder ones remain
-
OpinionReflections on rainwater
Water in the world’s pristine wildernesses is already unsafe to drink by new PFAS pollution standards
-
OpinionMay cause side effects
The dose makes the poison, but understanding unwanted drug interactions is complicated
-
OpinionFarsighted science
The Webb telescope looks set to deliver on its promise to change the way we see the universe
-
OpinionCan scientists communicate better with comedy?
It’s no joke: scientists and comedians are collaborating to share research
-
-
OpinionAlzheimer’s, amyloid and abandoned antibodies
Biogen’s aducanumab is stumbling into obscurity. Where does that leave the amyloid hypothesis?
-
OpinionEnergy is the Achilles’ heel of carbon capture technologies
Efforts to trap carbon dioxide could consume a huge amount of forecast renewable energy growth
-
OpinionCatalogues of complexity
The tangled web of fine chemicals supply frequently throws up surprises